Pyxis Oncology: Funding, Investors & Team (Sep 2026)
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer. The company has engaged in deep analyses of tumor antigen-specific tumor-infiltrating lymphocytes (TILs) within hot tumors and of tumor cell signaling pathways within cold tumors, providing laboratories with development of novel antibody-based immunotherapies. It was founded in 2019 and is based in Boston, Massachusetts.
Pyxis Oncology has raised $50.0M across 1 funding round on record, the most recent an undisclosed round of $50.0M announced in Jun 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Pyxis Oncology Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Pyxis Oncology Funding Rounds
Pyxis Oncology Founders and Leadership Team
No contact details are on record for this team yet.
Pyxis Oncology Funding Compared to Other Biotechnology Startups
Pyxis Oncology's latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pyxis Oncology in Biotechnology and Boston
Companies Similar to Pyxis Oncology
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Pyxis Oncology Funding FAQs
What does Pyxis Oncology do?
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer. The company has engaged in deep analyses of tumor antigen-specific tumor-infiltrating lymphocytes (TILs) within hot tumors and of tumor cell signaling pathways within cold tumors, providing laboratories with development of novel antibody-based immunotherapies. It was founded in 2019 and is based in Boston, Massachusetts.
How much funding has Pyxis Oncology raised?
Pyxis Oncology has raised $50.0M across 1 round on record. The most recent is an undisclosed round of $50.0M announced in Jun 2026.
When did Pyxis Oncology last raise funding?
Pyxis Oncology's most recent funding round on record is an undisclosed round of $50.0M, announced in Jun 2026.
Who founded Pyxis Oncology?
FundedIQ lists Lara S (Founder) at Pyxis Oncology.
Where is Pyxis Oncology headquartered?
Pyxis Oncology is based in Boston, Massachusetts, United States.
How many employees does Pyxis Oncology have?
Pyxis Oncology is in the 11-50 employee band.
How does Pyxis Oncology's funding compare to other Biotechnology startups?
Pyxis Oncology's latest round of $50.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Pyxis Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pyxis Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.